Tracy Neal, MD
Cardiovascular Disease · Cullman, ALNPI 1881664258
Payments from drug & device makers
Across 290 payments — averaging $2881.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corvista Health, Inc.$829K
- Medtronic$2K
- Merck$774
- Novartis$768
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$424
- E.r. Squibb & Sons, L.L.C.$419
- plus $2K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corvista Health, Inc. | 3 | $829,257 |
| Medtronic(2 entities) | 27 | $1,556 |
| Merck | 35 | $774 |
| Novartis | 64 | $768 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 24 | $424 |
| E.r. Squibb & Sons, L.L.C. | 14 | $419 |
| Abbott | 11 | $308 |
| Pfizer | 18 | $299 |
| Amgen | 17 | $240 |
| AstraZeneca | 12 | $154 |
| Sanofi-aventis U.S. LLC | 9 | $150 |
| Cvrx, Inc. | 2 | $136 |
| Boehringer Ingelheim | 5 | $101 |
| Bayer | 5 | $98 |
| Novo Nordisk | 4 | $95 |
| Lantheus Medical Imaging, Inc. | 5 | $83 |
| Alnylam Pharmaceuticals Inc. | 5 | $78 |
| Johnson & Johnson | 4 | $71 |
| Philips North America LLC | 4 | $61 |
| Boston Scientific | 1 | $60 |
| Elutia, Inc. | 1 | $53 |
| Medicomp Inc | 3 | $45 |
| Regeneron Healthcare Solutions, Inc. | 3 | $43 |
| Irhythm Technologies, Inc. | 2 | $32 |
| Medline Industries LP | 1 | $24 |
| Convatec Inc. | 1 | $24 |
| Vital Connect, Inc | 1 | $20 |
| Bridgebio Pharma, Inc. | 1 | $20 |
| GE HealthCare | 1 | $19 |
| Cleerly, Inc. | 1 | $18 |
| Terumo Medical Corporation | 1 | $18 |
| Osprey Medical Inc | 1 | $17 |
| Baxter Healthcare | 1 | $16 |
| G Medical Diagnostic Services, Inc. | 1 | $15 |
| Scpharmaceuticals Inc. | 1 | $13 |
| Lexicon Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$835,522 in reported general payments places this provider in the 95th percentile of 292 cardiovascular disease providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Cullman
- Mustafa AhmedBirmingham$2.5M
- Brian FoleyAlexander City$2.5M
- Andreas MuenchDothan$2M
- Alain BouchardBirmingham$1.9M
- William DavisAuburn$1.7M
- Walter HaughtHuntsville$1.6M
- Christopher BrownMobile$1.4M
- Shi-Chi ChengHuntsville$1.2M
- Mahomed SalameAnniston$1.2M
- Steven JonesBirmingham$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.